Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06479681 · ClinicalTrials.gov registry record · NA
A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Patients
A NA study of Alcohol Use Disorder, sponsored by Clemson University.
- Recruiting
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 2
- Study locations
NCT06479681: Recruiting NA study of Alcohol Use Disorder, sponsored by Clemson University.
NCT06479681 is a NA study of Alcohol Use Disorder that is actively recruiting participants, run by Clemson University. The registered enrollment target is 750 participants, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (131% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06479681, a NA study of Alcohol Use Disorder, is actively recruiting participants, sponsored by Clemson University.
- RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 2
- Study locations
Study Summary
The project objective is to rigorously evaluate the effectiveness of a peer recovery coaching intervention (called RC-Link) in patients hospitalized with medical complications from alcohol use on recovery outcomes guided by the new NIAAA definition of recovery, examine mechanisms of heavy drinking using daily ecological momentary assessment (EMA), and determine the program's cost-effectiveness using an randomized controlled trial (RCT) design. The primary outcomes are frequency of heavy drinking, biopsychosocial functioning, and remission from AUD.
Primary Outcome
This outcome will be measured using the Alcohol Timeline Follow Back (TLFB), a calendar-based, self-report survey. The TLFB is the most widely used measure of alcohol use frequency in treatment trials for AUD and has strong reliability and validity in diverse populations.
Conditions Studied
Interventions
- BEHAVIORAL Peer recovery coaching (PRC)
- BEHAVIORAL Brief Intervention (SBIRT)
Study Locations (2)
South Carolina
- Greenville Memorial Hospital - Greenville
- Oconee Memorial Hospital - Seneca
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2028-06-02 |
| Phase | NA |
What NCT06479681 shows while recruiting
NCT06479681 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 324-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (131% higher).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Peer recovery coaching (PRC) is the first listed.
NCT06479681 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06479681 about?
NCT06479681 is a clinical study titled "A Peer Recovery Coaching Intervention for Hospitalized Alcohol Use Disorder Patients". The project objective is to rigorously evaluate the effectiveness of a peer recovery coaching intervention (called RC-Link) in patients hospitalized with medical complications from alcohol use on recovery outcomes guided by the new NIAAA definition of recovery, examine mechanisms of heavy drinking u...
What is the current status of trial NCT06479681?
This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2024-04-25. Estimated completion is 2028-06-02.
What conditions does trial NCT06479681 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT06479681?
The interventions under investigation include: Peer recovery coaching (PRC) (BEHAVIORAL), Brief Intervention (SBIRT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06479681?
This trial is sponsored by Clemson University, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06479681 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06479681's enrollment target sits among peer trials
750 9th of 184 higher than 176 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI